We report the first-in-human safety and immunogenicity assessment of a prototype hexon chimeric adenovirus ( Ad ) serotype @ ( Ad@ ) vector containing the hexon hypervariable regions of Ad serotype @ ( Ad@ ) and expressing human immunodeficiency virus ( HIV ) type @ EnvA .